19
Participants
Start Date
November 15, 2018
Primary Completion Date
March 27, 2020
Study Completion Date
June 10, 2020
Nintedanib
stable dose
Pulmonary rehabilitation program
12 weeks
Icahn School of Medicine at Mount Sinai, New York
Temple University Hospital, Oaks
Pulmonary and Critical Care Associates of Baltimore, Towson
University of Virginia Health System, Charlottesville
Pulmonix, LLC, Greensboro
Miami VA Healthcare System, Miami
Coastal Pulmonary & Crit Care, St. Petersburg
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
The LaPorte County Institute for Clinical Research, Michigan City
University of Michigan Health System, Ann Arbor
Froedtert and The Medical College of Wisconsin, Milwaukee
St. Vincent Physicians Sleep and Respiratory Center, Billings
Glacier View Research Institute, Kalispell
Baylor University Medical Center, Dallas
Loma Linda University Medical Center, Loma Linda
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Western Connecticut Medical Group, Danbury
Metroplex Pul and Sleep Ctr, McKinney
Lead Sponsor
Boehringer Ingelheim
INDUSTRY